Literature DB >> 15853951

Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease.

Lauren Staple1, Timothy Andrews, Donna McDonald-McGinn, Elaine Zackai, Kathleen E Sullivan.   

Abstract

Humoral immunodeficiencies have a recognized association with atopy. This study investigated the association of a T-cell disorder (chromosome 22q11.2 deletion) and a neutrophil disorder [chronic granulomatous disease (CGD)] with asthma, eczema, and rhinitis using a standardized survey instrument. Patients were recruited from either a national referral center (chromosome 22q11.2 deletion syndrome) or from a registry (CGD). Controls consisted of siblings of patients. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) was found to be significantly associated with both eczema and asthma but not allergic rhinitis. CGD was not found to be significantly associated with atopic diseases. Copyright 2005 Blackwell Munksgaard

Entities:  

Mesh:

Year:  2005        PMID: 15853951     DOI: 10.1111/j.1399-3038.2005.00259.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  18 in total

1.  Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  R Zemble; E Luning Prak; K McDonald; D McDonald-McGinn; E Zackai; K Sullivan
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

Review 2.  Atopic Dermatitis and Allergic Urticaria: Cutaneous Manifestations of Immunodeficiency.

Authors:  Martin Robert Gaudinski; Joshua D Milner
Journal:  Immunol Allergy Clin North Am       Date:  2016-10-28       Impact factor: 3.479

3.  Reply to Narra.

Authors:  Esra Ozcan; Raif S Geha; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2009-06-01       Impact factor: 10.793

4.  De novo rates and selection of large copy number variation.

Authors:  Andy Itsara; Hao Wu; Joshua D Smith; Deborah A Nickerson; Isabelle Romieu; Stephanie J London; Evan E Eichler
Journal:  Genome Res       Date:  2010-09-14       Impact factor: 9.043

Review 5.  Nox enzymes in allergic airway inflammation.

Authors:  Albert van der Vliet
Journal:  Biochim Biophys Acta       Date:  2011-03-21

6.  Deficiency of gp91phox inhibits allergic airway inflammation.

Authors:  Carla M Sevin; Dawn C Newcomb; Shinji Toki; Wei Han; Taylor P Sherrill; Madison G Boswell; Zhou Zhu; Robert D Collins; Kelli L Boyd; Kasia Goleniewska; Matthew M Huckabee; Timothy S Blackwell; R Stokes Peebles
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

Review 7.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

8.  Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome.

Authors:  Y Kanaya; S Ohga; K Ikeda; K Furuno; T Ohno; H Takada; N Kinukawa; T Hara
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

9.  22q and two: 22q11.2 deletion syndrome and coexisting conditions.

Authors:  Jennifer L Cohen; Terrence B Crowley; Daniel E McGinn; Carey McDougall; Marta Unolt; Michele P Lambert; Beverly S Emanuel; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-09-23       Impact factor: 2.802

Review 10.  Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome.

Authors:  Blaine Crowley; Melanie Ruffner; Donna M McDonald McGinn; Kathleen E Sullivan
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.